- Home
- MNMD vs HBNC Comparison
MNMD vs HBNC Comparison
Compare MNMD & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNMD
- HBNC
- Stock Information
- Founded
- MNMD 2019
- HBNC 1873
- Country
- MNMD United States
- HBNC United States
- Employees
- MNMD N/A
- HBNC N/A
- Industry
- MNMD Pharmaceuticals and Biotechnology
- HBNC Major Banks
- Sector
- MNMD Health Care
- HBNC Finance
- Exchange
- MNMD Nasdaq
- HBNC Nasdaq
- Market Cap
- MNMD 709.9M
- HBNC 706.4M
- IPO Year
- MNMD N/A
- HBNC N/A
- Fundamental
- Price
- MNMD $9.61
- HBNC $16.62
- Analyst Decision
- MNMD Strong Buy
- HBNC Buy
- Analyst Count
- MNMD 7
- HBNC 3
- Target Price
- MNMD $24.71
- HBNC $19.67
- AVG Volume (30 Days)
- MNMD 1.1M
- HBNC 541.1K
- Earning Date
- MNMD 11-06-2025
- HBNC 10-22-2025
- Dividend Yield
- MNMD N/A
- HBNC 3.98%
- EPS Growth
- MNMD N/A
- HBNC 170.74
- EPS
- MNMD N/A
- HBNC 1.17
- Revenue
- MNMD N/A
- HBNC $211,582,000.00
- Revenue This Year
- MNMD N/A
- HBNC $47.63
- Revenue Next Year
- MNMD N/A
- HBNC $4.03
- P/E Ratio
- MNMD N/A
- HBNC $13.74
- Revenue Growth
- MNMD N/A
- HBNC 19.27
- 52 Week Low
- MNMD $4.70
- HBNC $12.70
- 52 Week High
- MNMD $11.02
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- MNMD 53.63
- HBNC 58.40
- Support Level
- MNMD $8.70
- HBNC $15.96
- Resistance Level
- MNMD $10.04
- HBNC $16.49
- Average True Range (ATR)
- MNMD 0.50
- HBNC 0.38
- MACD
- MNMD 0.00
- HBNC -0.05
- Stochastic Oscillator
- MNMD 73.88
- HBNC 64.15
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.